# Aprea Therapeutics, Inc.: Form 8-K, filed Jan 9, 2026

- Company: [Aprea Therapeutics, Inc.](/companies/apre.md) (CIK 1781983)
- Form: 8-K
- Filed: 2026-01-09
- Accepted by EDGAR: Jan 9, 2026, 16:30 ET
- Period: 2026-01-09
- Accession: 0001104659-26-002490
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1781983/000110465926002490/apre-20260109x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1781983/000110465926002490/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1781983/000110465926002490/apre-20260109x8k.htm

Filed Jan 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-002490. Last ingested by Listed: Nov 4, 2026, 08:47 ET. No prices; not investment advice.